Study of Aspirin in Patients With Vestibular Schwannoma
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is a phase II prospective, randomized, double-blind, longitudinal study evaluating
whether the administration of aspirin can delay or slow tumor growth and maintain or improve
hearing in VS patients.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Collaborators:
Massachusetts General Hospital United States Department of Defense